General Cannabis Correlations
| CANN Stock | USD 0.04 0 2.73% |
The current 90-days correlation between General Cannabis Corp and Element Solutions is -0.16 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as General Cannabis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if General Cannabis Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
General Cannabis Correlation With Market
Very good diversification
The correlation between General Cannabis Corp and DJI is -0.22 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding General Cannabis Corp and DJI in the same portfolio, assuming nothing else is changed.
General |
The ability to find closely correlated positions to General Cannabis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace General Cannabis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back General Cannabis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling General Cannabis Corp to buy it.
Moving against General OTC Stock
| 0.48 | NTNX | Nutanix Earnings Call This Week | PairCorr |
| 0.47 | T | ATT Inc Aggressive Push | PairCorr |
| 0.45 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.45 | WMT | Walmart Aggressive Push | PairCorr |
| 0.41 | VZ | Verizon Communications Aggressive Push | PairCorr |
| 0.38 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.35 | GE | GE Aerospace Fiscal Year End 28th of January 2025 | PairCorr |
| 0.35 | PG | Procter Gamble | PairCorr |
| 0.34 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.33 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
| 0.31 | MSB | Mesabi Trust | PairCorr |
| 0.31 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between General OTC Stock performing well and General Cannabis OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze General Cannabis' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ESI | 1.29 | 0.08 | 0.06 | 0.20 | 1.30 | 3.77 | 11.06 | |||
| OEC | 2.21 | (0.19) | (0.01) | 0.04 | 2.56 | 5.81 | 15.71 | |||
| MTX | 1.31 | (0.06) | 0.04 | 0.09 | 1.30 | 2.94 | 11.90 | |||
| NGVT | 3.02 | 0.21 | 0.12 | 0.20 | 2.79 | 8.28 | 21.33 | |||
| HWKN | 1.67 | (0.12) | 0.00 | 0.06 | 2.48 | 3.27 | 12.56 | |||
| CRKN | 4.36 | (1.66) | 0.00 | (7.00) | 0.00 | 7.87 | 35.24 | |||
| CMT | 1.92 | (0.25) | (0.06) | 0.00 | 2.14 | 3.97 | 13.85 | |||
| BCPC | 1.11 | (0.02) | 0.00 | 0.10 | 1.26 | 2.64 | 8.32 | |||
| NEU | 1.14 | (0.19) | 0.00 | (0.02) | 0.00 | 2.47 | 10.57 | |||
| REX | 1.58 | (0.18) | (0.06) | 0.00 | 2.19 | 3.13 | 10.87 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in General Cannabis without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
| All Next | Launch Module |
General Cannabis Corporate Management
Elected by the shareholders, the General Cannabis' board of directors comprises two types of representatives: General Cannabis inside directors who are chosen from within the company, and outside directors, selected externally and held independent of General. The board's role is to monitor General Cannabis' management team and ensure that shareholders' interests are well served. General Cannabis' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, General Cannabis' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Timothy Brown | Chief Director | Profile | |
| Allyson Feiler | Chief Director | Profile | |
| Loree Schwartz | Chief Officer | Profile | |
| Jessica Bast | CFO Officer | Profile | |
| Bryan DeHaven | Managing Co | Profile | |
| David Hirst | Managing Supply | Profile | |
| Amie Rakoczy | VP Admin | Profile |